Immunic, Inc.
IMUX • NASDAQ
Immunic, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Daniel Vitt, with a market cap of $117.5M.
Market Cap$117.5M
Employees80.0
CEODaniel Vitt
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 1 weekAfter Market Close · Q1 2026
Financials
Immunic, Inc. FAQ
Common questions about Immunic, Inc.
Immunic, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026 after market close.
Immunic, Inc. has approximately 80 employees.